Guinea-Bissau vs Philippines: The number of people with susceptibility test result for rifampicin
Guinea-Bissau
89.04
in 2021
Philippines
88.57
in 2021
Guinea-Bissau rank
70th
Philippines rank
73rd
The number of people with susceptibility test result for rifampicin over time
- Guinea-Bissau
- Philippines
How they compare
Guinea-Bissau currently reports 89.04 against 88.57 in Philippines, a difference of 0.47.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Philippines ahead.
Guinea-Bissau ranks 70th and Philippines ranks 73rd of 146 countries.
Philippines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.23 | 27.62 | 26.39 | Philippines |
| 2020s | 73.23 | 86.74 | 13.51 | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guinea-Bissau or Philippines?
- Guinea-Bissau, at 89.04 against 88.57 in Philippines as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guinea-Bissau and Philippines?
- 0.47, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Philippines?
- 5 years are reported by both, from 2017 to 2021.
- How do Guinea-Bissau and Philippines rank globally for the number of people with susceptibility test result for rifampicin?
- Guinea-Bissau ranks 70th and Philippines ranks 73rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.